61 related articles for article (PubMed ID: 20141440)
1. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in DNA excision repair pathway contribute to the chemosensitivity and prognosis of acute myeloid leukemia.
Zhang A; Liu W; Guo X; Jia H; Wei Y; Can C; He N; Ji C; Ma D
Clin Chim Acta; 2024 May; 558():117899. PubMed ID: 38574942
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer.
Liu J; Deng N; Xu Q; Sun L; Tu H; Wang Z; Xing C; Yuan Y
Oncotarget; 2016 Jul; 7(30):48130-48142. PubMed ID: 27340861
[TBL] [Abstract][Full Text] [Related]
4. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
Mosrati MA; Willander K; Falk IJ; Hermanson M; Höglund M; Stockelberg D; Wei Y; Lotfi K; Söderkvist P
Oncotarget; 2015 Sep; 6(28):25109-20. PubMed ID: 26298771
[TBL] [Abstract][Full Text] [Related]
5. Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer.
Xu Y; Cheng L; Dai H; Zhang R; Wang M; Shi T; Sun M; Cheng X; Wei Q
J Cell Mol Med; 2018 Oct; 22(10):4975-4984. PubMed ID: 30055028
[TBL] [Abstract][Full Text] [Related]
6. Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway.
Padella A; Fontana MC; Marconi G; Fonzi E; Petracci E; Ferrari A; Baldazzi C; Papayannidis C; Ghelli Luserna Di Rorá A; Testoni N; Castellani G; Haferlach T; Martinelli G; Simonetti G
Blood Cancer J; 2021 Jan; 11(1):7. PubMed ID: 33414401
[No Abstract] [Full Text] [Related]
7. Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.
Xu P; Chen B; Feng J; Cheng L; Xia G; Li Y; Qian J; Ding J; Lu Z
Int J Hematol; 2012 Oct; 96(4):450-60. PubMed ID: 22968471
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.
Douzi K; Ouerhani S; Menif S; Safra I; Abbes S
Leuk Lymphoma; 2015 Jun; 56(6):1856-62. PubMed ID: 25311495
[TBL] [Abstract][Full Text] [Related]
9. The Role of DNA Repair (
Crișan AS; Tripon F; Bogliș A; Crauciuc GA; Trifa AP; Lázár E; Macarie I; Gabor MR; Bănescu C
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541232
[No Abstract] [Full Text] [Related]
10. Structural modeling and analyses of genetic variations in the human XPC nucleotide excision repair protein.
Le J; Min JH
J Biomol Struct Dyn; 2023; 41(23):13535-13562. PubMed ID: 36890638
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma Pigmentosum Complementation Group C (XPC): Emerging Roles in Non-Dermatologic Malignancies.
Nasrallah NA; Wiese BM; Sears CR
Front Oncol; 2022; 12():846965. PubMed ID: 35530314
[TBL] [Abstract][Full Text] [Related]
12. Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations.
Shabashvili DE; Feng Y; Kaur P; Venugopal K; Guryanova OA
Exp Hematol; 2022 Jun; 110():20-27. PubMed ID: 35306047
[TBL] [Abstract][Full Text] [Related]
13. DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks.
Venugopal K; Feng Y; Nowialis P; Xu H; Shabashvili DE; Berntsen CM; Kaur P; Krajcik KI; Taragjini C; Zaroogian Z; Casellas Román HL; Posada LM; Gunaratne C; Li J; Dupéré-Richer D; Bennett RL; Pondugula S; Riva A; Cogle CR; Opavsky R; Law BK; Bhaduri-McIntosh S; Kubicek S; Staber PB; Licht JD; Bird JE; Guryanova OA
Clin Cancer Res; 2022 Feb; 28(4):756-769. PubMed ID: 34716195
[TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum and acute myeloid leukemia: a case report.
Bencharef H; Lamchahab M; Dassouli D; Sraidi S; Guennoun B; Hda N; Oukkache B; Quessar A
J Med Case Rep; 2021 Aug; 15(1):437. PubMed ID: 34446105
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.
Sharifi Z; Faranoush M; Mohseni A; Rostami S; Ramzi M; Sharifi MJ
Per Med; 2019 Nov; 16(6):479-490. PubMed ID: 31647372
[No Abstract] [Full Text] [Related]
16. HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics.
Lai TH; Mitchell S; Wu PJ; Orwick S; Liu C; Ravikrishnan J; Woyach J; Mims A; Plunkett W; Puduvalli VK; Byrd JC; Lapalombella R; Sampath D
Leuk Lymphoma; 2019 Sep; 60(9):2308-2311. PubMed ID: 30773117
[No Abstract] [Full Text] [Related]
17. Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma.
Yang L; Xu M; Cui CB; Wei PH; Wu SZ; Cen ZJ; Meng XX; Huang QG; Xie ZC
Cancer Manag Res; 2018; 10():5313-5328. PubMed ID: 30464628
[TBL] [Abstract][Full Text] [Related]
18. PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma.
Sharpe MA; Raghavan S; Baskin DS
Oncotarget; 2018 May; 9(35):23923-23943. PubMed ID: 29844863
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants in ERCC1 and XPC predict survival outcome of non-small cell lung cancer patients treated with platinum-based therapy.
Zhang R; Jia M; Xue H; Xu Y; Wang M; Zhu M; Sun M; Chang J; Wei Q
Sci Rep; 2017 Sep; 7(1):10702. PubMed ID: 28878296
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
